Australia markets open in 5 hours 26 minutes

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
63.92-1.76 (-2.67%)
As of 02:34PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 81.83B
Enterprise value 102.30B
Trailing P/E 182.44
Forward P/E 17.15
PEG ratio (5-yr expected) 0.82
Price/sales (ttm)3.00
Price/book (mrq)4.67
Enterprise value/revenue 3.73
Enterprise value/EBITDA 21.38

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3-13.95%
S&P500 52-week change 326.14%
52-week high 387.87
52-week low 363.89
50-day moving average 368.46
200-day moving average 375.20

Share statistics

Avg vol (3-month) 36.96M
Avg vol (10-day) 35.53M
Shares outstanding 51.25B
Implied shares outstanding 61.25B
Float 81.24B
% held by insiders 10.11%
% held by institutions 187.95%
Shares short (15 May 2024) 421.7M
Short ratio (15 May 2024) 42.92
Short % of float (15 May 2024) 41.74%
Short % of shares outstanding (15 May 2024) 41.74%
Shares short (prior month 15 Apr 2024) 421.18M

Dividends & splits

Forward annual dividend rate 43.08
Forward annual dividend yield 44.69%
Trailing annual dividend rate 33.02
Trailing annual dividend yield 34.60%
5-year average dividend yield 44.00
Payout ratio 4838.89%
Dividend date 327 June 2024
Ex-dividend date 414 June 2024
Last split factor 22:1
Last split date 328 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 1.77%
Operating margin (ttm)34.43%

Management effectiveness

Return on assets (ttm)10.50%
Return on equity (ttm)2.39%

Income statement

Revenue (ttm)27.45B
Revenue per share (ttm)22.00
Quarterly revenue growth (yoy)5.30%
Gross profit (ttm)N/A
Net income avi to common (ttm)485M
Diluted EPS (ttm)0.36
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.06B
Total cash per share (mrq)4.86
Total debt (mrq)25.19B
Total debt/equity (mrq)144.34%
Current ratio (mrq)1.08
Book value per share (mrq)14.08

Cash flow statement

Operating cash flow (ttm)8.48B
Levered free cash flow (ttm)8.89B